Clene Inc. (CLNNW)
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
Icecure Medical Ltd (ICCM)
IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense® Sales
Clene Inc. (CLNN)
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
Xenon Pharmaceuticals Inc (XENE)
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference
Disc Medicine Inc (IRON)
Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026
Vicarious Surgical Inc (RBOT)
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
Myriad Genetics Inc (MYGN)
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
ORIC Pharmaceuticals Inc (ORIC)
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
Mereo BioPharma (MREO)
Mereo BioPharma Provides Corporate Update
TransMedics Group Inc. (TMDX)
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts